MUC1 and neoplasm: further revealed that MUC1-ST binding to Siglec-9 promotes differentiation of monocytes into tumor-associated macrophages (TAMs), which recruit neutrophils, inhibit T cell function, and promote tumor cell invasion, closely associated with poor prognosis in breast cancer patients (93).